Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines. - Wikidata - awgldk - TriplyDB

Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.

Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.

http://www.wikidata.org/entity/Q34009362

about

Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer.Monocyte-derived DC maturation strategies and related pathways: a transcriptional view Designing the optimal vaccine: the importance of cytokines and dendritic cells.IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN Cellular immunotherapy using dendritic cells against multiple myeloma DNA is an efficient booster of dendritic cell-based vaccine Update on vaccine development for renal cell cancer.Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.Immunobiology of human mucin 1 in a preclinical ovarian tumor model.Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists.Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.Dendritic cell subsets as vectors and targets for improved cancer therapy Dendritic cells: are they clinically relevant?Dendritic cells and immunity against cancer.Recent developments in cancer vaccines Therapeutic vaccines in renal cell carcinoma.Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.Phenotypic plasticity of MDSC in cancers.NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo.Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma.Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen.Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma.

P2860

Q34018782-9A33EBB6-6FCE-468A-A145-087CB1A6B47A Q34216061-CD9D38D0-553B-4187-B931-CF970700BF3E Q34757261-7D4FCF67-2B94-4C05-A981-1002C5ABFFA0 Q34916497-091A7455-DAD6-406B-86F8-36AA69EBCA73 Q35146556-2FDA6183-426A-41E4-B90F-3B4445F9D28F Q35156105-550E7E02-23A6-46C2-8570-A5F36EA802D5 Q35174485-37C8D74E-4C80-4580-A75B-86775FD4A7CB Q35865581-A384AD68-2D9A-4534-823F-FA408632F141 Q36256389-A25E265E-4869-4099-890A-AFB5DB438F42 Q36989720-8E7F2C16-92EE-4B72-8AF2-8DE01486DC2D Q37225501-88766731-9E7E-4391-A0CF-5AA055A01B62 Q37448957-3B366CEF-135D-4074-AB03-5200C4A72288 Q37527861-E7330AA3-657B-4001-BD08-B728B5A4F47E Q37728235-B70CBA02-6F30-42EF-9144-5172E4CB974C Q37735454-7E83DD7B-00A7-4D6D-979E-E4941A49274F Q37758502-E749F79F-6D12-4CB6-967C-BA49DEC4D982 Q37778692-6E70224A-9D5F-457E-9FE7-90F0B388C68B Q37821074-843265E6-D5F3-4C41-B284-D93711F87F03 Q37830226-EF74E30C-8511-4FBA-ABF0-7A58ED0B60A7 Q37922585-B8573710-09D2-4C86-B66A-86BAB05CFAA9 Q38031222-A5610AD6-8B6A-495F-A37B-466473AD6114 Q38047054-83F39874-D876-4CE8-A823-1A9153A89C13 Q39390511-640E9DC2-00AC-4052-947A-344DE7B94ECD Q39520906-5926C6F5-46B5-4D45-876F-DE024CF8BC4D Q41092396-C26C319B-BE1C-4316-A86B-1A64BF5994B9 Q42556531-4BA728A6-99BE-41DC-B604-1F65E2766CAE Q45344940-4ACD5BB5-41AA-4A11-8C08-AFBC5B2A068F Q55457224-26A1A43D-F3AC-47B9-8A24-ABB58E4066C5

P2860

Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.

http://www.wikidata.org/entity/Q34009362

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@ast

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@en

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@nl

type

label

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@ast

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@en

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@nl

prefLabel

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@ast

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@en

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@nl

P1433

Q34009362-BC36FAB5-BB4A-4BB2-B394-65B247529936

P1476

Q34009362-CAF5707E-08DF-4F5E-BCFF-179772B1D41C

P2093

Q34009362-15CDED52-32F8-4141-818B-F0562636DBBB

Q34009362-51B40A3D-FA6F-4954-B096-84AF410F5779

Q34009362-B3F63440-747C-4735-82F4-A6C9F3EDA90A

Q34009362-C8E4BC33-AC69-41A9-81BA-589E3ED0E4D3

Q34009362-CA58519D-56D4-4AEC-B847-CA646523A331

Q34009362-CDBC8749-4BFC-4D1B-886D-C38E48921AF7

Q34009362-D7746540-5E70-4CD3-9C0D-91DD0A195373

P2860

Q34009362-0857D2A9-EBC4-4B86-B422-42C07F2FF102

Q34009362-08A397D1-0522-4D36-B498-78DEA799DFD8

Q34009362-08BE1F7C-91DE-4687-ACC2-591D965AB935

Q34009362-17BCDD56-6EB4-4237-8C8E-DF42E904E215

Q34009362-2D7981BA-F492-4F4D-96AE-2A3E3CEA4CA7

Q34009362-37C34149-D64D-40CE-AFF4-690F7D00013B

Q34009362-383813DF-C0F6-4206-B06F-1ADAE7B84EAA

Q34009362-548E857B-2F71-485B-9E55-C6C92B56D0AE

Q34009362-5E17AD8C-32C3-47C5-8EB4-D3147F4C807D

Q34009362-6B20B00F-F232-4737-9DAB-C8F32DADBC61

P2888

Q34009362-842CB1C7-2293-46DB-9AD0-18265E4D7370

P304

Q34009362-D87AC44C-694E-452A-91CE-6ED830D2E75F

P31

Q34009362-0500C5D1-8AC2-4F6E-82BD-DCC2FAEBFBDD

P356

Q34009362-8465C004-77F3-41DC-9DA4-498D40C9937C

P433

Q34009362-8007CBD9-2C6D-4A5F-A3B7-F775F48CB3BC

P478

Q34009362-0BE742DD-C248-4083-B197-1F9AA3D2E482

P577

Q34009362-9E612B4A-4AA6-4A9C-8764-CBDE7B6E1FE8

P5875

Q34009362-95F83C93-BA2E-4461-9358-C8486E85A6F1

P6179

Q34009362-B2A37D3B-8FD1-4388-BD4F-53DC531D82F2

P698

Q34009362-1E9481AA-B46E-49AB-87DF-4565E403C27F

P932

Q34009362-BDD7BF22-6DB6-4D54-BF21-CA7B1D5DC96D

P356

S00262-008-0648-5

P1433

Cancer Immunology, Immunotherapy

P1476

Type-1 polarized dendritic cel ...... d activity as cancer vaccines.

@en

P2093

Adam S Giermasz

http://www.w3.org/2001/XMLSchema#string

Julie A Urban

http://www.w3.org/2001/XMLSchema#string

Pawel Kalinski

http://www.w3.org/2001/XMLSchema#string

Payal Watchmaker

http://www.w3.org/2001/XMLSchema#string

Rachel L Cumberland

http://www.w3.org/2001/XMLSchema#string

William Gooding

http://www.w3.org/2001/XMLSchema#string

Yutaro Nakamura

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes

Dendritic cells and the control of immunity

Identification and expression of mouse Langerin (CD207) in dendritic cells

Interleukin-12 and the regulation of innate resistance and adaptive immunity

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

Memory CD8+ T cells protect dendritic cells from CTL killing.

Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity.

Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses.

Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.

Dendritic cells as therapeutic vaccines against cancer.

P2888

s00262-008-0648-5

P304

1329-1336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-008-0648-5

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23804246

http://www.w3.org/2001/XMLSchema#string

P6179

1039135375

http://www.w3.org/2001/XMLSchema#string

P698

19156413

http://www.w3.org/2001/XMLSchema#string

P932

2907477

http://www.w3.org/2001/XMLSchema#string